AVAX Technologies Inc. announced the expansion of its executive team with the appointment of Adele Sommerfeld as Chief Executive Officer. Ms. Sommerfeld joins the company management team with a breadth of experience within the biotechnology industry, spanning over 25 years. She brings significant experience across functional areas including biotechnology equity financing transactions, corporate strategy, strategic partnering, and business development.